{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:38:40Z","timestamp":1791520720364,"version":"4.3.4"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["grant R01-DA052214"],"award-info":[{"award-number":["grant R01-DA052214"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>An important challenge to addressing the opioid overdose crisis is the lack of information on the size of the population of people who misuse opioids (PWMO) in local areas. This estimate is needed for better resource allocation, estimation of treatment and overdose outcome rates using appropriate denominators (ie, the population at risk), and proper evaluation of intervention effects. In this study, we used a bayesian hierarchical spatiotemporal integrated abundance model that integrates multiple types of county-level surveillance outcome data, state-level information on opioid misuse, and covariates to estimate the latent (hidden) numbers of PWMO and latent prevalence of opioid misuse across New York State counties (2007-2018). The model assumes that each opioid-related outcome reflects a partial count of the number of PWMO, and it leverages these multiple sources of data to circumvent limitations of parameter estimation associated with other types of abundance models. Model estimates showed a reduction in the prevalence of PWMO during the study period, with important spatial and temporal variability. The model also provided county-level estimates of rates of treatment and opioid overdose using the numbers of PWMO as denominators. This modeling approach can identify the sizes of hidden populations to guide public health efforts in confronting the opioid overdose crisis across local areas.<\/jats:p>\n               <jats:p>This article is part of a Special Collection on Mental Health.<\/jats:p>","DOI":"10.1093\/aje\/kwae018","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T14:40:03Z","timestamp":1709908803000},"page":"959-967","source":"Crossref","is-referenced-by-count":10,"title":["Estimation of the prevalence of opioid misuse in New York State counties, 2007-2018: a bayesian spatiotemporal abundance model approach"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3060-5994","authenticated-orcid":false,"given":"Julian","family":"Santaella-Tenorio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2940-088X","authenticated-orcid":false,"given":"Staci A","family":"Hepler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4860-2791","authenticated-orcid":false,"given":"Ariadne","family":"Rivera-Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6183-3303","authenticated-orcid":false,"given":"David M","family":"Kline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8441-7046","authenticated-orcid":false,"given":"Magdalena","family":"Cerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"issue":"6408","key":"2024070914262684100_ref1","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau1184","article-title":"Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016","volume":"361","author":"Jalal","year":"2018","journal-title":"Science."},{"key":"2024070914262684100_ref2","author":"Ahmad"},{"key":"2024070914262684100_ref3","author":"National Center for Health Statistics"},{"key":"2024070914262684100_ref4","volume-title":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2018 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration","year":"2019"},{"issue":"522","key":"2024070914262684100_ref5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/01621459.2017.1285775","article-title":"Hidden population size estimation from respondent-driven sampling: a network approach","volume":"113","author":"Crawford","year":"2018","journal-title":"J Am Stat Assoc."},{"issue":"1","key":"2024070914262684100_ref6","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1214\/14-EJS923","article-title":"Estimating hidden population size using respondent-driven sampling data","volume":"8","author":"Handcock","year":"2014","journal-title":"Electron J Stat."},{"issue":"1","key":"2024070914262684100_ref7","first-page":"15","article-title":"Estimating the prevalence of problematic drug use: a review of methods and their application","volume":"54","author":"Hickman","year":"2002","journal-title":"Bull Narcotics"},{"issue":"12","key":"2024070914262684100_ref8","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/aje\/kwac154","article-title":"Opioid use disorder among Ohio\u2019s Medicaid population: prevalence estimates from 19 counties using a multiplier method","volume":"191","author":"Doogan","year":"2022","journal-title":"Am J Epidemiol."},{"issue":"12","key":"2024070914262684100_ref9","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1111\/add.15111","article-title":"Estimating the prevalence of problem drug use from drug-related mortality data","volume":"115","author":"Jones","year":"2020","journal-title":"Addiction."},{"key":"2024070914262684100_ref10","doi-asserted-by":"crossref","DOI":"10.7249\/RR3117","volume-title":"The Future of Fentanyl and Other Synthetic Opioids","author":"Pardo","year":"2019"},{"issue":"5152","key":"2024070914262684100_ref11","first-page":"1419","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"2","key":"2024070914262684100_ref12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4310\/SII.2015.v8.n2.a1","article-title":"Estimating the sizes of populations at risk of HIV infection from multiple data sources using a Bayesian hierarchical model","volume":"8","author":"Bao","year":"2015","journal-title":"Stat Interface."},{"issue":"12","key":"2024070914262684100_ref13","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2105\/AJPH.2018.304673","article-title":"Estimated prevalence of opioid use disorder in Massachusetts, 2011-2015: a capture-recapture analysis","volume":"108","author":"Barocas","year":"2018","journal-title":"Am J Public Health."},{"issue":"3","key":"2024070914262684100_ref14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/add.13222","article-title":"Problem drug use prevalence estimation revisited: heterogeneity in capture-recapture and the role of external evidence","volume":"111","author":"Jones","year":"2016","journal-title":"Addiction."},{"key":"2024070914262684100_ref15","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109710","article-title":"The prevalence of opioid use disorder in Kentucky\u2019s counties: a two-year multi-sample capture-recapture analysis","volume":"242","author":"Thompson","year":"2023","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"2024070914262684100_ref16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jrsssa\/qnac013","article-title":"An integrated abundance model for estimating county-level prevalence of opioid misuse in Ohio","volume":"186","author":"Hepler","year":"2023","journal-title":"J R Stat Soc Ser A Stat Soc."},{"issue":"2","key":"2024070914262684100_ref17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2656.2009.01632.x","article-title":"Hierarchical modelling and estimation of abundance and population trends in metapopulation designs","volume":"79","author":"Kery","year":"2010","journal-title":"J Anim Ecol."},{"issue":"1","key":"2024070914262684100_ref18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.0006-341X.2004.00142.x","article-title":"N-mixture models for estimating population size from spatially replicated counts","volume":"60","author":"Royle","year":"2004","journal-title":"Biometrics."},{"issue":"3","key":"2024070914262684100_ref19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.0006-341X.2002.00540.x","article-title":"Integrating mark-recapture-recovery and census data to estimate animal abundance and demographic parameters","volume":"58","author":"Besbeas","year":"2002","journal-title":"Biometrics."},{"issue":"suppl 1","key":"2024070914262684100_ref20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10336-010-0632-7","article-title":"Integrated population models: a novel analysis framework for deeper insights into population dynamics","volume":"152","author":"Schaub","year":"2011","journal-title":"J Ornithol."},{"issue":"3","key":"2024070914262684100_ref21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/2041-210X.12329","article-title":"Estimates from non-replicated population surveys rely on critical assumptions","volume":"6","author":"Knape","year":"2014","journal-title":"Methods Ecol Evol."},{"issue":"1","key":"2024070914262684100_ref22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.econlet.2012.06.001","article-title":"Identification issues in some double-index models for non-negative data","volume":"117","author":"Papadopoulos","year":"2012","journal-title":"Econ Lett."},{"key":"2024070914262684100_ref23","author":"National Center for Health Statistics"},{"key":"2024070914262684100_ref24","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research","author":"World Health Organization","year":"1993"},{"key":"2024070914262684100_ref25","author":"Healthcare Cost and Utilization Project"},{"key":"2024070914262684100_ref26","author":"Statewide Planning and Research Cooperative System"},{"key":"2024070914262684100_ref27","volume-title":"International Classification of Diseases Ninth Revision. Basic Tabulation List With Alphabetical Index","author":"World Health Organization","year":"1978"},{"key":"2024070914262684100_ref28","author":"IQVIA Xponent Database 2006-2019","year":"2021"},{"key":"2024070914262684100_ref29","author":"New York State Department of Health"},{"key":"2024070914262684100_ref30","author":"Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration (SAMHSA)"},{"key":"2024070914262684100_ref31","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)"},{"key":"2024070914262684100_ref32","author":"US Census Bureau"},{"key":"2024070914262684100_ref33","author":"Office of Policy Development and Research, US Department of Housing and Urban Development","year":"2022"},{"key":"2024070914262684100_ref34","author":"New York State Division of Criminal Justice Services"},{"key":"2024070914262684100_ref35","volume-title":"New York\/New Jersey High Intensity Drug Trafficking Area Drug Market Analysis","author":"Drug Enforcement Agency, US Department of Justice","year":"2007"},{"issue":"154","key":"2024070914262684100_ref36","first-page":"1","article-title":"NCHS urban-rural classification scheme for counties","author":"Ingram","year":"2012","journal-title":"Vital Health Stat 2."},{"key":"2024070914262684100_ref37","author":"US Census Bureau"},{"issue":"1","key":"2024070914262684100_ref38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/sta4.94","article-title":"Spatio-temporal change of support with application to American Community Survey multi-year period estimates","volume":"4","author":"Bradley","year":"2015","journal-title":"Stat."},{"issue":"2","key":"2024070914262684100_ref39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/10618600.2016.1172487","article-title":"Programming with models: writing statistical algorithms for general model structures with NIMBLE","volume":"26","author":"Valpine","year":"2017","journal-title":"J Comput Graph Stat."},{"key":"2024070914262684100_ref40","author":"Hepler","year":"24, 2023"},{"key":"2024070914262684100_ref41","volume-title":"New York State Opioid Annual Report 2019","author":"New York State Department of Health","year":"2019"},{"issue":"1","key":"2024070914262684100_ref42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/1471-2458-12-443","article-title":"Estimating the prevalence of illicit opioid use in New York City using multiple data sources","volume":"12","author":"McNeely","year":"2012","journal-title":"BMC Public Health."},{"issue":"3","key":"2024070914262684100_ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC Clinical Practice Guideline for prescribing opioids for pain\u2014United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep."},{"issue":"6","key":"2024070914262684100_ref44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention\u2019s 2016 opioid guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med."},{"key":"2024070914262684100_ref45","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103308","article-title":"Opioid dosing among patients with 3 or more years of continuous prescription opioid use before and after the CDC opioid prescribing guideline","volume":"97","author":"Salas","year":"2021","journal-title":"Int J Drug Policy."},{"issue":"11","key":"2024070914262684100_ref46","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1377\/hlthaff.2021.00135","article-title":"CDC guideline for opioid prescribing associated with reduced dispensing to certain patients with chronic pain","volume":"40","author":"Townsend","year":"2021","journal-title":"Health Aff (Millwood)."},{"issue":"10","key":"2024070914262684100_ref47","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1377\/hlthaff.2018.0512","article-title":"Assessing the impact of state policies for prescription drug monitoring programs on high-risk opioid prescriptions","volume":"37","author":"Bao","year":"2018","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"2024070914262684100_ref48","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/add.16087","article-title":"Impacts of the New York State COVID-19 disaster emergency orders on prescription dispensing for opioids and medication for opioid use disorder","volume":"118","author":"Suri","year":"2023","journal-title":"Addiction."},{"key":"2024070914262684100_ref49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jsat.2018.07.008","article-title":"Comparison between buprenorphine provider availability and opioid deaths among US counties","volume":"93","author":"Jones","year":"2018","journal-title":"J Subst Abuse Treat."},{"key":"2024070914262684100_ref50","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107549","article-title":"Data quality considerations when using county-level opioid overdose death rates to inform policy and practice","volume":"204","author":"Jones","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"2024070914262684100_ref51","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/add.14144","article-title":"Corrected US opioid-involved drug poisoning deaths and mortality rates, 1999-2015","volume":"113","author":"Ruhm","year":"2018","journal-title":"Addiction."},{"key":"2024070914262684100_ref52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.annepidem.2021.12.013","article-title":"What is the prevalence of drug use in the general population? Simulating underreported and unknown use for more accurate national estimates","volume":"68","author":"Levy","year":"2022","journal-title":"Ann Epidemiol."}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/aje\/advance-article-pdf\/doi\/10.1093\/aje\/kwae018\/56901816\/kwae018.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/193\/7\/959\/58483327\/kwae018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/193\/7\/959\/58483327\/kwae018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T15:45:37Z","timestamp":1720539937000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article\/193\/7\/959\/7623014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,3,6]]},"published-print":{"date-parts":[[2024,7,8]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwae018","relation":{},"ISSN":["0002-9262","1476-6256"],"issn-type":[{"value":"0002-9262","type":"print"},{"value":"1476-6256","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,3,6]]}}}